Yukitaka Ideyama

Promoting Effects and Mechanismsof Action of Androgen in BladderCarcinogenesis in Male Rats

Seiki Imada, Hideyuki Akaza, Yoshihiro Ami et al. · European Urology · 1997 · 96 citations

Medicine, Endocrinology, Oncology +14

A five-alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats

Sadamu Tsukamoto, Hideyuki Akaza, Mizuki Onozawa et al. · Cancer · 1998 · 69 citations · Full text

Medicine, Oncology, Pharmacology +17

YM-201627: An orally active antitumor agent with selective inhibition of vascular endothelial cell proliferation

Nobuaki Amino, Yukitaka Ideyama, Mayumi Yamano et al. · Cancer Letters · 2005 · 52 citations

Medicine, Oncology, Pharmacology +9

Inhibitory effects of a novel aromatase inhibitor, YM511, on growth of endometrial explants and insulin-like growth factor-I gene expression in rats with experimental endometriosis

Masafumi Kudoh, Yoko Susaki, Yukitaka Ideyama et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1997 · 42 citations

Medicine, Endocrinology, Gynecology +10

Novel nonsteroidal inhibitor of cytochrome P45017α (17α-hydroxylase/C17–20 lyase), YM116, decreased prostatic weights by reducing serum concentrations of testosterone and adrenal androgens in rats

Yukitaka Ideyama, Masafumi Kudoh, Kyoko Tanimoto et al. · The Prostate · 1998 · 35 citations

Medicine, Endocrinology, Pharmacology +17